Emerging Medical Therapies for the Treatment of Obesity in Women with Cardiovascular Diseases

PURPOSE OF REVIEW: In this review, the impact of obesity on cardiovascular disease in women and emerging anti-obesity pharmacologic treatments are discussed. RECENT FINDINGS: Robust evidence demonstrates the burden of obesity across the lifespan in women and links obesity to a diverse set of cardiov...

Descripción completa

Detalles Bibliográficos
Autores principales: Behrooz, Leili, Lenneman, Carrie G., Hamburg, Naomi M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Women and Cardiovascular Health (N Goldberg and S Lewis, Section Editors)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682277/
https://www.ncbi.nlm.nih.gov/pubmed/37874468
http://dx.doi.org/10.1007/s11886-023-01961-z
_version_ 1785150946868723712
author Behrooz, Leili
Lenneman, Carrie G.
Hamburg, Naomi M.
author_facet Behrooz, Leili
Lenneman, Carrie G.
Hamburg, Naomi M.
author_sort Behrooz, Leili
collection PubMed
description PURPOSE OF REVIEW: In this review, the impact of obesity on cardiovascular disease in women and emerging anti-obesity pharmacologic treatments are discussed. RECENT FINDINGS: Robust evidence demonstrates the burden of obesity across the lifespan in women and links obesity to a diverse set of cardiovascular diseases. Female-specific risk factors including sex hormones and pregnancy factors intersect with obesity and cardiovascular risk. Sustained weight loss has potential for cardiovascular benefits. Recent trials demonstrate cardiovascular benefits of emerging agents with weight loss effects including GLP-1 RA and SGLT2 inhibitors in women. SUMMARY: Treatment and prevention strategies for cardiovascular disease in obese women should include integration of weight management strategies including the targeted use of emerging pharmacologic therapies.
format Online
Article
Text
id pubmed-10682277
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-106822772023-11-30 Emerging Medical Therapies for the Treatment of Obesity in Women with Cardiovascular Diseases Behrooz, Leili Lenneman, Carrie G. Hamburg, Naomi M. Curr Cardiol Rep Women and Cardiovascular Health (N Goldberg and S Lewis, Section Editors) PURPOSE OF REVIEW: In this review, the impact of obesity on cardiovascular disease in women and emerging anti-obesity pharmacologic treatments are discussed. RECENT FINDINGS: Robust evidence demonstrates the burden of obesity across the lifespan in women and links obesity to a diverse set of cardiovascular diseases. Female-specific risk factors including sex hormones and pregnancy factors intersect with obesity and cardiovascular risk. Sustained weight loss has potential for cardiovascular benefits. Recent trials demonstrate cardiovascular benefits of emerging agents with weight loss effects including GLP-1 RA and SGLT2 inhibitors in women. SUMMARY: Treatment and prevention strategies for cardiovascular disease in obese women should include integration of weight management strategies including the targeted use of emerging pharmacologic therapies. Springer US 2023-10-24 2023 /pmc/articles/PMC10682277/ /pubmed/37874468 http://dx.doi.org/10.1007/s11886-023-01961-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Women and Cardiovascular Health (N Goldberg and S Lewis, Section Editors)
Behrooz, Leili
Lenneman, Carrie G.
Hamburg, Naomi M.
Emerging Medical Therapies for the Treatment of Obesity in Women with Cardiovascular Diseases
title Emerging Medical Therapies for the Treatment of Obesity in Women with Cardiovascular Diseases
title_full Emerging Medical Therapies for the Treatment of Obesity in Women with Cardiovascular Diseases
title_fullStr Emerging Medical Therapies for the Treatment of Obesity in Women with Cardiovascular Diseases
title_full_unstemmed Emerging Medical Therapies for the Treatment of Obesity in Women with Cardiovascular Diseases
title_short Emerging Medical Therapies for the Treatment of Obesity in Women with Cardiovascular Diseases
title_sort emerging medical therapies for the treatment of obesity in women with cardiovascular diseases
topic Women and Cardiovascular Health (N Goldberg and S Lewis, Section Editors)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682277/
https://www.ncbi.nlm.nih.gov/pubmed/37874468
http://dx.doi.org/10.1007/s11886-023-01961-z
work_keys_str_mv AT behroozleili emergingmedicaltherapiesforthetreatmentofobesityinwomenwithcardiovasculardiseases
AT lennemancarrieg emergingmedicaltherapiesforthetreatmentofobesityinwomenwithcardiovasculardiseases
AT hamburgnaomim emergingmedicaltherapiesforthetreatmentofobesityinwomenwithcardiovasculardiseases

Ejemplares similares